Michael Singer
Director/Board Member at BIOPORTO A/S
Net worth: 16 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Morch Eriksen | M | 64 | 11 years | |
| Carsten Brunn | M | 53 |
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | 1 years |
| Metin Kurtoglu | M | 46 |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | 8 years |
| Murat Kalayoglu | M | 51 |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | 8 years |
| Toby Fox | M | - |
Neutrolis, Inc.
 Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation. | - |
| Abdul Hakkim | M | - |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation. | - |
| Konstantinos Tzortzakis | M | - |
Anodyne Nanotech, Inc.
 Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | 5 years |
| Jan Kuhlmann Andersen | M | 63 | 9 years | |
| Jake Lombardo | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | 5 years |
| Matthew Bartholomae | M | - | 1 years | |
| Chris Jewell | M | 43 |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | 1 years |
| Milos Miljkovic | M | 40 |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | 3 years |
| Donnie Hardison | M | 74 | 3 years | |
| John McDonough | M | 65 | 3 years | |
| Hojatollah Rezaei Nejad | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | 5 years |
| Prasad Devarajan | M | - | 2 years | |
| Ursula Klause | M | - | 4 years | |
| Jennifer Zonderman | F | - | 5 years | |
| Kate Xiong | F | - |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation. | 6 years |
| Andy Stewart | M | - | - | |
| Kristen Baldwin | F | - | - | |
| Timothy Springer | M | 76 | 1 years | |
| Lampros Kourtis | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | - |
| Michael Singer | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | 4 years |
| Achilleas Gravanis | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | - |
| Carrie Cox | F | 66 | 1 years | |
| Chihiro Hosoya | F | - |
Pykus Therapeutics, Inc.
 Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | 5 years |
| James Stefater | M | - |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | 8 years |
| Tomasz P. Stryjewski | M | - |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | 8 years |
| Emily English | M | - | 1 years | |
| Carl Berke | M | - |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | 6 years |
| Jeff T. Mihm | M | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | 1 years |
| Nishan de Silva | M | 51 | 1 years | |
| Blaine Davis | M | 50 | 1 years | |
| Timothy Barabe | M | 71 | 1 years | |
| Patrick Zenner | M | 77 | 1 years | |
| Zhang Yi | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Lindop | M | 67 | - | |
| Kirsten Drejer | M | 68 | 4 years | |
| Ole Larsen | M | 59 | 3 years | |
| Jan Leth Christensen | M | - | 3 years | |
| Thomas Magnussen | M | 71 | 8 years | |
| Anthony Pare | M | 62 | 3 years | |
| Torben Arnth Nielsen | M | 64 | 8 years | |
| Aymeric Sallin | M | 50 | 1 years | |
| Neil A. Goldman | M | 56 | - | |
| Scott Myers | M | 57 | - | |
| Christopher Bird | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 19 | 39.58% |
| Denmark | 16 | 33.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Singer
- Personal Network
